Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted', indicating that study results have been submitted.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed (may or may not relate to the study), replaces the previous provenance wording, and the revision tag updated to v3.3.2.SummaryDifference0.1%

- Check35 days agoChange DetectedRemoved the government funding status notice, a site-wide banner about potential delays and operating status, which is not part of the study specifics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedThe screenshots show no changes to the core study content (title, eligibility criteria, interventions, outcomes); only minor layout adjustments and updated timestamps are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%

- Check85 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.